FoundationOne CDx (F1CDx)
FDA premarket approval P170019/S019 · decided 2020-07-24
Approval details
- PMA number
- P170019
- Supplement
- S019
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- FoundationOne CDx (F1CDx)
- Generic name
- Next generation sequencing oncology panel, somatic or germline variant detection system
- Applicant
- Foundation Medicine, Inc.
- Date received
- 2020-04-27
- Decision date
- 2020-07-24
- Days to decision
- 88 days
- Decision code
- APPR
- Product code
- PQP
- Advisory committee
- Pathology
- Expedited review
- No
- Location
- Boston, MA
- Statement
- Approval of software infrastructure modifications for FoundationOne CDx (F1CDx), including modifications involving migrating the analysis pipeline and associated software to the Amazon Web Services (AWS) cloud.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.